JP2018102202A - Green leaf powder and composition - Google Patents
Green leaf powder and composition Download PDFInfo
- Publication number
- JP2018102202A JP2018102202A JP2016252075A JP2016252075A JP2018102202A JP 2018102202 A JP2018102202 A JP 2018102202A JP 2016252075 A JP2016252075 A JP 2016252075A JP 2016252075 A JP2016252075 A JP 2016252075A JP 2018102202 A JP2018102202 A JP 2018102202A
- Authority
- JP
- Japan
- Prior art keywords
- green
- green leaf
- leaf powder
- composition
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Preparation Of Fruits And Vegetables (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本発明は、緑葉粉末及びそれを用いた組成物並びに緑葉粉末の製造方法に関する。 The present invention relates to a green leaf powder, a composition using the same, and a method for producing the green leaf powder.
従来、緑葉粉末を含む組成物は、青汁等の健康食品等として知られている。青汁等の原料としては、大麦、明日葉、ケール等の各種の植物が知られている(特許文献1)。 Conventionally, compositions containing green leaf powder are known as health foods such as green juice. As raw materials such as green juice, various plants such as barley, tomorrow, and kale are known (Patent Document 1).
健康食品等に用いる緑葉粉末については、需要者のニーズは近年多様化しており、更なる効果の向上を求める要求、特に健康や美容の観点における更なる効果の向上を求める要求がますます強くなっている。
しかしながら、従来の緑葉粉末やそれを含む組成物は、この要求に十分にこたえるものではなかった。
With regard to green leaf powder used in health foods, etc., the needs of consumers have diversified in recent years, and there is an increasing demand for further improvement in effect, particularly in terms of health and beauty. ing.
However, the conventional green leaf powder and the composition containing the same have not sufficiently met this requirement.
そこで、本発明者は、緑葉粉末及びそれを含む組成物について、健康や美容の観点から更なる作用強化が得られる構成について鋭意検討した。その結果、驚くべきことに、ケイ素含有量を一定以上含有する緑葉粉末及びそれを含む組成物は、筋芽細胞賦活効果、筋肉細胞分化促進効果、及び脂肪細胞分化抑制効果を奏し、筋肉組織の賦活及び増強、脂肪組織増加抑制並びにそれによる代謝促進や肥満の防止及び低減用途において有用でありうることを見出し、本発明を完成するに至った。 Then, this inventor earnestly examined about the structure which can obtain the further effect | action reinforcement | strengthening from a viewpoint of health or beauty about green leaf powder and a composition containing the same. As a result, surprisingly, the green leaf powder containing a certain amount or more of silicon content and the composition containing the same have a myoblast activation effect, a muscle cell differentiation promoting effect, and an adipocyte differentiation inhibiting effect, It has been found that it can be useful for activation and enhancement, suppression of adipose tissue increase, metabolism promotion and obesity prevention and reduction, thereby completing the present invention.
本発明は上記の知見に基づくものであり、ケイ素含有量が質量基準で1,000ppm以上である経口用緑葉粉末を提供するものである。 The present invention is based on the above findings and provides an oral green leaf powder having a silicon content of 1,000 ppm or more on a mass basis.
また本発明は緑葉粉末を含有する青汁用の飲食用組成物であって、該粉末のケイ素含有量が質量基準で1,000ppm以上である青汁用の飲食用組成物を提供するものである。 The present invention also provides a food and drink composition for green juice containing green leaf powder, wherein the silicon content of the powder is 1,000 ppm or more on a mass basis. is there.
また本発明は緑葉粉末を含有するダイエット用組成物であって、該粉末のケイ素含有量が質量基準で1,000ppm以上であるダイエット用組成物を提供するものである。 The present invention also provides a diet composition containing green leaf powder, wherein the silicon content of the powder is 1,000 ppm or more on a mass basis.
また本発明は緑葉粉末を含有する美容用組成物であって、該粉末のケイ素含有量が質量基準で1,000ppm以上である美容用組成物を提供するものである。 The present invention also provides a cosmetic composition containing green leaf powder, wherein the powder has a silicon content of 1,000 ppm or more on a mass basis.
本発明によれば、筋芽細胞賦活効果、筋肉細胞分化促進効果及び脂肪細胞分化抑制効果を有し、筋肉増強や代謝促進、肥満の予防ないし低減等のダイエット効果に優れた緑葉粉末及びそれを用いた青汁用の飲食用組成物が提供される。また本発明によれば、筋芽細胞賦活効果、筋肉細胞分化促進効果及び脂肪細胞分化抑制効果に優れたダイエット用組成物を提供することができる。 According to the present invention, a green leaf powder having a myoblast activation effect, a muscle cell differentiation promoting effect and an adipocyte differentiation inhibiting effect, and having excellent diet effects such as muscle enhancement, metabolism promotion, obesity prevention or reduction, and the like. The used food and drink composition for green juice is provided. Moreover, according to this invention, the composition for diets excellent in the myoblast activation effect, the muscle cell differentiation promotion effect, and the adipocyte differentiation suppression effect can be provided.
以下、本発明の緑葉粉末及び組成物並びに緑葉粉末の製造方法について、その好ましい実施形態に基づいて説明する。本実施形態の緑葉粉末は、ケイ素含有量が質量基準で1,000ppm以上である経口用の緑葉粉末である。また本実施形態の組成物は、ケイ素含有量が質量基準で1,000ppm以上である緑葉粉末を含有するものである。以下、本実施形態の組成物という場合、青汁用の飲食用組成物、ダイエット用組成物及び美容用組成物のいずれにも当てはまる。 Hereinafter, the green leaf powder and composition of the present invention and the method for producing the green leaf powder will be described based on preferred embodiments thereof. The green leaf powder of this embodiment is an oral green leaf powder having a silicon content of 1,000 ppm or more on a mass basis. Moreover, the composition of this embodiment contains the green leaf powder whose silicon content is 1,000 ppm or more on a mass basis. Hereinafter, the composition of the present embodiment applies to any of the composition for eating and drinking for green juice, the composition for diet and the cosmetic composition.
緑葉は、緑色植物の葉である。本実施形態の緑葉は、それ自体緑色をしているものである。緑色植物としては、飲食品用途に適するとともに、緑葉粉末に特定の高ケイ素含有量を与えうるものが選択される。この観点から、本実施形態において、緑色植物としては、麦類、イネ、あわ、笹、ひえ、きび、とうもろこし、ソルガム、さとうきびのようなイネ科植物が特に好ましく挙げられる。イネ科植物としては、特に筋肉細胞分化促進効果が高いことから、麦類が好ましい。麦類としては、大麦、小麦、えん麦、ライ麦、クマザサが好ましく挙げられ、ダイエット作用の点から大麦が最も好ましい。大麦としては、二条大麦、六条大麦、裸大麦などを特に制限なく用いることができる。 Green leaves are leaves of green plants. The green leaf of this embodiment itself is green. As a green plant, what is suitable for food-drinks use and can give a specific high silicon content to a green leaf powder is selected. From this point of view, in the present embodiment, particularly preferable examples of the green plant include grasses such as wheat, rice, sweet potato, persimmon, fin, acne, corn, sorghum and sugar cane. As the gramineous plant, wheat is preferable because of its particularly high effect of promoting the differentiation of muscle cells. As the barley, barley, wheat, oats, rye and kumazasa are preferably mentioned, and barley is most preferred from the viewpoint of dieting action. As barley, Nijo barley, Rojo barley, bare barley and the like can be used without particular limitation.
本実施形態において、緑葉とは、植物体の葉の部分だけではなく、葉とともに茎を含んでもよい。従って、緑葉粉末は、茎の粉末を含んでいてもよい。この場合、茎の粉末を含む緑葉粉末のケイ素含有量が質量基準で1,000ppm以上であることが示されれば、緑葉粉末のケイ素含有量が質量基準で1,000ppm以上であるとする。後述する好ましいケイ素含有量範囲についても同様である。なお、ここでいう茎は、脇芽を含んでいてもよい。 In the present embodiment, the green leaf may include not only a leaf portion of a plant body but also a stem together with the leaf. Therefore, the green leaf powder may contain stem powder. In this case, if it is shown that the silicon content of the green leaf powder including the stem powder is 1,000 ppm or more on the mass basis, the silicon content of the green leaf powder is assumed to be 1,000 ppm or more on the mass basis. The same applies to the preferable silicon content range described later. In addition, the stalk here may contain the side bud.
上述した通り、本実施形態における緑葉粉末は、質量基準で1,000ppm以上のケイ素を含有する。これにより、緑葉粉末は、筋芽細胞賦活効果、筋肉細胞分化促進効果及び脂肪細胞分化抑制効果が高いものである。また緑葉粉末のケイ素含有量は質量基準で1,000,000ppm以下であることが、筋芽細胞賦活効果及び筋肉細胞分化促進効果、特に筋芽細胞賦活効果を高める点や、緑葉粉末の繊維量を低減して経口しやすいものとしやすい点から好ましい。これらの観点から、より好ましくは、緑葉粉末は質量基準で3,000ppm以上100,000ppm以下のケイ素を含有し、更に好ましくは、質量基準で5,000ppm以上80,000ppm以下のケイ素を含有し、とりわけ好ましくは、質量基準で7,000ppm以上50,000ppm以下のケイ素を含有する。緑葉粉末のケイ素含有量は後述する実施例に記載の方法にて測定することができる。上記緑葉粉末のケイ素含有量を上記範囲とするためには、例えば、後述する好適な緑葉粉末の製造方法により緑葉粉末を製造すればよい。特に、その過程において、繊維を多く含む形態である粉砕末又は細片化物粉末を製造することで上記ケイ素含有量の緑葉粉末、特にケイ素を質量基準で7,000ppm以上含有する緑葉粉末を容易に得やすくなる。 As described above, the green leaf powder in the present embodiment contains 1,000 ppm or more of silicon on a mass basis. Thereby, the green leaf powder has high myoblast activation effect, muscle cell differentiation promoting effect and adipocyte differentiation inhibiting effect. In addition, the silicon content of the green leaf powder is 1,000,000 ppm or less on the basis of mass, so that the myoblast activation effect and the muscle cell differentiation promoting effect, particularly the myoblast activation effect, and the fiber amount of the green leaf powder It is preferable because it is easy to be taken orally by reducing the amount. From these viewpoints, more preferably, the green leaf powder contains 3,000 ppm or more and 100,000 ppm or less silicon on a mass basis, and more preferably contains 5,000 ppm or more and 80,000 ppm or less silicon on a mass basis, Particularly preferably, 7,000 ppm or more and 50,000 ppm or less of silicon is contained on a mass basis. The silicon content of the green leaf powder can be measured by the method described in Examples described later. In order to make the silicon content of the green leaf powder within the above range, for example, the green leaf powder may be produced by a suitable method for producing the green leaf powder described below. In particular, in the process, green leaf powder having the above-mentioned silicon content, particularly green leaf powder containing more than 7,000 ppm of silicon on a mass basis can be easily produced by producing a powdered or pulverized powder having a high fiber content. It becomes easy to obtain.
本実施形態の緑葉粉末において、ケイ素は通常、二酸化ケイ素(シリカ)の形態で存在している。 In the green leaf powder of the present embodiment, silicon is usually present in the form of silicon dioxide (silica).
緑葉粉末は水分量を20質量%以下、特に10質量%以下とすることが、安定性や品質劣化の防止等の観点から好ましい。水分量は例えば、1質量%以上であることが、緑葉粉末の製造容易性の点から好ましい。 The green leaf powder preferably has a water content of 20% by mass or less, particularly 10% by mass or less from the viewpoint of stability and prevention of quality deterioration. For example, the water content is preferably 1% by mass or more from the viewpoint of ease of production of the green leaf powder.
緑葉粉末は、30〜250メッシュの何れかのふるいを通過する粉末であることが、他の成分との混合のしやすさや経口しやすさ等の点で好ましい。同様の観点から、緑葉粉末は90質量%以上が200メッシュを通過することがより好ましい。 The green leaf powder is preferably a powder that passes through any of 30 to 250 mesh sieves in terms of ease of mixing with other components and ease of oral administration. From the same viewpoint, it is more preferable that 90% by mass or more of the green leaf powder passes through 200 mesh.
緑葉粉末としては、緑葉の各種の加工物を用いることができる。そのような加工物としては、例えば、緑葉に乾燥処理及び粉砕処理を施してなる乾燥粉砕末(単に「乾燥粉末」と呼ばれることもある)、緑葉に細片化処理を施してなる細片化物粉末、緑葉の搾汁を乾燥してなる搾汁粉末、緑葉のエキスを乾燥してなるエキス末等が挙げられるが、ケイ素含有量を上記の範囲としたものをより得やすくする点から、緑葉の乾燥粉砕末及び細片化物粉末が好ましく、製造の容易性や経口しやすさの点から緑葉の乾燥粉砕末が最も好ましい。緑葉粉末は粒状、顆粒状などを当然に含むものである。また、緑葉粉末は造粒物であってもよい。 As green leaf powder, various processed products of green leaf can be used. Examples of such processed products include dry pulverized powder obtained by subjecting green leaves to drying treatment and pulverization treatment (sometimes referred to simply as “dry powder”), and pulverization treatment obtained by subjecting green leaves to fragmentation treatment. Examples include powders, squeezed powders obtained by drying green leaf juice, and extract powders obtained by drying green leaf extract. From the viewpoint of making it easier to obtain a silicon content within the above range, green leaves The dry pulverized powder and the powdered product of the green leaf are preferable, and the dry pulverized powder of green leaves is most preferable from the viewpoint of easy production and ease of oral administration. Naturally, green leaf powder includes granular and granular forms. The green leaf powder may be a granulated product.
上記の筋芽細胞賦活効果、筋肉細胞増殖促進効果及び脂肪細胞分化抑制効果を一層高める点から、本実施形態の組成物の固形分中、緑葉粉末の含有量は、乾燥質量で、5質量%以上が好ましく、10質量%以上がより好ましく、15質量%以上が更に好ましく、20質量%以上が特に好ましい。また本実施形態の組成物は緑葉粉末のみからなるものであってもよいが、他成分との組み合わせで高機能化及び多機能化を図ることを可能する観点から、組成物中の緑葉粉末の上限値としては、90質量%以下が好ましく、85質量%以下がより好ましく、80質量%以下が更に好ましい。 From the viewpoint of further enhancing the myoblast activation effect, the muscle cell proliferation promoting effect, and the adipocyte differentiation inhibiting effect, the content of the green leaf powder in the solid content of the composition of the present embodiment is 5% by mass in dry mass. The above is preferable, 10% by mass or more is more preferable, 15% by mass or more is further preferable, and 20% by mass or more is particularly preferable. In addition, the composition of the present embodiment may be composed only of green leaf powder, but from the viewpoint of achieving high functionality and multi-function in combination with other components, the green leaf powder of the composition As an upper limit, 90 mass% or less is preferable, 85 mass% or less is more preferable, and 80 mass% or less is still more preferable.
本実施形態の組成物は、特定のケイ素含有量を有する緑葉粉末以外に、その他の成分を含んでいてもよい。前記のその他の成分としては、例えば、ビタミン類、タンパク質、オリゴ糖、ミネラル類、乳製品、植物加工品、乳酸菌などの微生物、糖類、甘味料、クエン酸、酸味料、着色料、光沢剤のほか、タルク、セルロース、ステアリン酸カルシウム等の製造用剤等を配合することができる。その他の成分としては、これら以外にも、種々の賦形剤、結合剤、滑沢剤、安定剤、希釈剤、増量剤、乳化剤、着色料、香料、食品添加物、調味料などを挙げることができる。その他の成分の含有量は、組成物の形態等に応じて適宜選択することができる。本実施形態において、組成物に含まれる特定のケイ素含有量を有する緑葉粉末以外の成分は、固形分中、90質量%以下であることが好ましく、80質量%以下であることが特に好ましい。 The composition of this embodiment may contain other components in addition to the green leaf powder having a specific silicon content. Examples of the other components include vitamins, proteins, oligosaccharides, minerals, dairy products, processed plant products, microorganisms such as lactic acid bacteria, sugars, sweeteners, citric acid, acidulants, colorants, and brighteners. In addition, production agents such as talc, cellulose, calcium stearate and the like can be blended. Examples of other components include various excipients, binders, lubricants, stabilizers, diluents, extenders, emulsifiers, coloring agents, fragrances, food additives, seasonings and the like. Can do. The content of other components can be appropriately selected according to the form of the composition. In this embodiment, it is preferable that components other than the green leaf powder which has the specific silicon content contained in a composition are 90 mass% or less in solid content, and it is especially preferable that it is 80 mass% or less.
本実施形態の組成物は、固体状、半固体状、流動体状等のいずれの形態であってもよい。例えば固体状としては、錠状、棒状、板状、ブロック状、固形状、丸状、飴状、タブレット状、グミ状、ウエハース状、ビスケット状、クッキー状、ケーキ状、チュアブル状、スティック状等が挙げられる。半固体状としては、ペースト状、ゼリー状、クリーム状、ゲル状等が挙げられる。流動体状としては、シロップ状、液状、クリーム状、ゲル状等が挙げられる。 The composition of the present embodiment may be in any form such as solid, semi-solid, and fluid. For example, solid forms include tablets, sticks, plates, blocks, solids, rounds, bowls, tablets, gummi, wafers, biscuits, cookies, cakes, chewables, sticks, etc. Is mentioned. Examples of the semi-solid form include a paste form, a jelly form, a cream form, and a gel form. Examples of the fluid form include a syrup form, a liquid form, a cream form, and a gel form.
本実施形態の青汁用の飲食用組成物について以下詳述する。青汁用の飲食用組成物とは、緑葉を各種加工物として含む飲料である。青汁用の飲食用組成物としては、この飲料、及びこの飲料を得るために液体に分散又は溶解させる固体が挙げられる。特に、組成物は、粉末状又は顆粒状であって、水と混合した混合物を経口摂取する形態であると、腐敗を防ぎ長期保存に適するとともに、この飲食用組成物が水と混合した時に色が鮮やかであることから好ましい。また組成物が固体状の形態である場合、上述したように、これを水と混合した液状体となし、該液状体を飲用する等経口摂取することができるが、摂取する者の好み等に応じて、固体のまま経口摂取してもよい。また水だけでなく、牛乳、豆乳、果汁飲料、乳清飲料、清涼飲料、ヨーグルト、ホットケーキミックス等に添加して使用してもよい。また、サプリメント、健康食品、栄養機能食品、機能性表示食品、特定保健用食品、及び医薬品として用いても良いことは言うまでもない。青汁用の飲食用組成物には、一般的に知られる青汁製品以外にスムージーなどが含まれる。 The food and drink composition for green juice of this embodiment will be described in detail below. The food and drink composition for green juice is a beverage containing green leaves as various processed products. Examples of the composition for eating and drinking for green juice include this beverage and a solid that is dispersed or dissolved in a liquid to obtain this beverage. In particular, when the composition is in the form of powder or granules and is ingested orally with a mixture mixed with water, it is suitable for long-term storage while preventing spoilage, and when the composition for eating and drinking is mixed with water. Is preferable because it is vivid. Further, when the composition is in a solid form, as described above, it is made into a liquid mixed with water, and can be taken orally, such as drinking the liquid. Accordingly, it may be taken orally as a solid. Further, not only water but also milk, soy milk, fruit juice drink, whey drink, soft drink, yogurt, hot cake mix and the like may be used. Moreover, it cannot be overemphasized that you may use as a supplement, health food, functional nutrition food, functional indication food, food for specified health, and a pharmaceutical. The food and drink composition for green juice includes smoothies and the like in addition to the generally known green juice products.
本実施形態のダイエット用組成物及び美容用組成物の形態は青汁用の飲食用組成物の例として挙げた飲料及びこの飲料を得るために液体に分散又は溶解させる固体の形態に限らず、任意の形態を採用できる。また本実施形態のダイエット用組成物及び美容用組成物についても、サプリメント、健康食品、栄養機能食品、機能性表示食品、特定保健用食品、及び医薬品として用いても良いことは言うまでもない。 The form of the composition for diet and the composition for beauty of this embodiment is not limited to the beverage mentioned as an example of the composition for eating and drinking for green juice and the solid form dispersed or dissolved in the liquid to obtain this beverage, Any form can be adopted. In addition, it goes without saying that the diet composition and cosmetic composition of the present embodiment may be used as supplements, health foods, nutritional functional foods, functional display foods, foods for specified health use, and pharmaceuticals.
以下、本実施形態の粉末の好適な製造方法について更に説明する。
本実施形態の製造方法は、火山灰土にてイネ科植物を栽培し、該イネ科植物の緑葉を粉末化するものである。
火山灰土は結晶質又は非晶質のケイ酸が多く含まれており植物へのケイ素供給力が高い。またイネ科植物はケイ素吸収性の高い植物である。このため、本実施形態の製造方法によれば、上記のケイ素含有量を含有する緑葉粉末を得やすいものとなる。火山灰土は一般に10質量%以上、例えばSiO2換算で20〜50質量%程度のケイ素を含有することが知られている。
火山灰土としては、黒ボク土、多湿黒ボク土、黒ボクグライ土が知られているが、黒ボク土がイネ科植物の生育の点から特に好ましい。黒ボク土は、母材である火山灰土と腐植で構成された黒色の土である。表層は腐植が多いため色は黒色又は黒褐色、下層は褐色となる。火山山麓の台地や平地でよく見られる。
Hereinafter, the suitable manufacturing method of the powder of this embodiment is further demonstrated.
In the production method of the present embodiment, a grass plant is cultivated in volcanic ash soil, and green leaves of the grass plant are pulverized.
Volcanic ash soil contains a lot of crystalline or amorphous silicic acid and has a high silicon supply capacity to plants. Gramineae plants are plants with high silicon absorption. For this reason, according to the manufacturing method of this embodiment, it becomes easy to obtain the green leaf powder containing said silicon content. It is known that volcanic ash soil generally contains 10% by mass or more of silicon, for example, about 20-50% by mass in terms of SiO 2 .
As the volcanic ash soil, black mysterious soil, moist black mysterious soil and black mysterious soil are known, and black mysterious soil is particularly preferable from the viewpoint of the growth of gramineous plants. Kuroboku soil is black soil composed of volcanic ash soil and humus as the base materials. Since the surface layer has a lot of humus, the color is black or black brown, and the lower layer is brown. It is often seen on plateaus and flatlands at the foot of the volcano.
黒ボク土は、通常知られている黒ボク土であれば特に限定されないが、例えば、主に火山灰土と腐葉土からなり、黒色に近い色をしており、ボクボクした感触(軽くてサラサラしている)の土であると知られている。また、黒ボク土は、赤土と比べると、有効態リン酸の含有量が小さく、N:P比が2〜5:12〜17程度である。したがって、イネ科植物を黒ボク土で栽培した場合、イネ科植物に対して過剰なリンの供給を回避できる。さらに、黒ボク土は、赤土より、陽イオン交換量が2倍程度多い。これにより、黒ボク土は、赤土と比較して、豊富な量の交換性石灰、交換性苦土及び交換性加里を含有する傾向にある。 The black soil is not particularly limited as long as it is a commonly known black soil, but for example, it is mainly composed of volcanic ash soil and humus and has a color close to black. It is known to be the soil. Moreover, compared with red soil, black meso soil has a small content of effective phosphoric acid, and N: P ratio is about 2-5: 12-17. Therefore, when a gramineous plant is cultivated with black soil, excessive phosphorus supply to the gramineous plant can be avoided. Furthermore, black soil has about twice as much cation exchange amount as red soil. As a result, black soil tends to contain an abundant amount of exchangeable lime, exchangeable clay, and exchangeable potassium compared to red soil.
本実施形態の製造方法は、火山灰土のみによりイネ科植物を栽培してもよいが、火山灰土以外の土、例えば、赤色土や黄色土等を一部含んでいてもよい。火山灰土と火山灰土以外の土との混合土により栽培する場合、火山灰土の割合は、使用する混合土の100質量部に対して50質量部以上であることが好ましく、70質量部以上であることが好ましく、90質量部以上であることがより好ましい。 The production method of the present embodiment may cultivate gramineous plants using only volcanic ash soil, but may include some soil other than volcanic ash soil, such as red soil and yellow soil. When cultivating with mixed soil of volcanic ash soil and soil other than volcanic ash soil, the proportion of volcanic ash soil is preferably 50 parts by mass or more and 100 parts by mass or more with respect to 100 parts by mass of the mixed soil used. It is preferably 90 parts by mass or more.
栽培とは、当業界において通常知られる方法により大麦を種や苗などから葉や茎を収穫できる程度にまで生育させることであれば特に限定されず、使用する土以外の温度や湿度などの条件は当業者により適宜設定することができる。 Cultivation is not particularly limited as long as barley is grown to the extent that leaves and stems can be harvested from seeds and seedlings by a method commonly known in the art, and conditions such as temperature and humidity other than the soil to be used Can be appropriately set by those skilled in the art.
採取するイネ科植物の緑葉は組成物の美観に影響することから、濃緑色であることが好ましい。具体的には、葉色スケールを用いた場合、1本のイネ科植物の葉の平均値が例えば4.0以上であり、好ましくは4.5以上である。 Since the green leaves of the gramineous plant to be collected affect the beauty of the composition, it is preferably dark green. Specifically, when a leaf color scale is used, the average value of the leaves of one gramineous plant is, for example, 4.0 or more, and preferably 4.5 or more.
緑葉は、例えば麦類では、成熟期前、すなわち分けつ開始期から出穂開始前期に収穫されることが好ましい。緑葉は収穫後、直ちに処理されることが好ましい。処理までに時間を要する場合、緑葉の変質を防ぐために低温貯蔵などの当業者が通常用いる貯蔵手段により貯蔵される。 For example, in the case of wheat, green leaves are preferably harvested before the maturity period, that is, from the beginning of splitting to the beginning of heading. The green leaves are preferably treated immediately after harvesting. When time is required for processing, it is stored by storage means commonly used by those skilled in the art, such as cold storage, in order to prevent deterioration of green leaves.
例えば、緑葉を乾燥粉末化するには従来公知の方法を用いることができる。そのような方法としては、緑葉に対して、乾燥処理及び粉砕処理を組み合わせた方法を用いることができる。乾燥処理及び粉砕処理はいずれを先に行ってもよいが、乾燥処理を先に行うことが好ましい。乾燥粉末化は、この方法に、更に必要に応じブランチング処理、殺菌処理などの処理から選ばれる1種又は2種以上の処理を組み合わせてもよい。また、粉砕処理を行う回数は1回でも、2回以上の処理を組合せてもよいが、粗粉砕処理を行った後に、より細かく粉砕する微粉砕処理を組合せることが好ましい。 For example, conventionally known methods can be used to dry green leaves. As such a method, a method combining drying treatment and pulverization treatment with respect to green leaves can be used. Either the drying process or the pulverization process may be performed first, but the drying process is preferably performed first. Dry powdering may be combined with one or more treatments selected from treatments such as blanching treatment and sterilization treatment, if necessary. In addition, the number of times of pulverization may be one time or a combination of two or more processes, but it is preferable to combine a fine pulverization process that finely pulverizes after the coarse pulverization process.
ブランチング処理とは、緑葉の緑色を鮮やかに保つための処理であり、ブランチング処理の方法としては、熱水処理や蒸煮処理などが挙げられる。ブランチング処理は、80〜100℃、好ましくは90〜100℃の熱水または水蒸気中で、緑葉を60〜180秒間、好ましくは90〜120秒間処理することが好ましい。また、ブランチング処理として熱水処理を行う場合、熱水中に炭酸マグネシウムなどの炭酸塩や炭酸水素ナトリウムなどの炭酸水素塩を溶解させておくことで、緑葉の緑色をより鮮やかにすることができるため、好ましい。また、蒸煮処理としては、常圧または加圧下において、緑葉を水蒸気により蒸煮する処理と冷却する処理とを繰り返す間歇的蒸煮処理が好ましい。間歇的蒸煮処理において、水蒸気により蒸煮する処理は、好ましくは20〜40秒間、より好ましくは30秒間行われる。蒸煮処理後の冷却処理は、直ちに行われることが好ましく、その方法は、特に制限しないが、冷水への浸漬、冷蔵、冷風による冷却、温風による気化冷却、温風と冷風を組み合わせた気化冷却などが用いられる。このうち温風と冷風を組み合わせた気化冷却が好ましい。このような冷却処理は、緑葉の品温が、好ましくは60℃以下、より好ましくは50℃以下、最も好ましくは40℃以下となるように行われる。また、ビタミン、ミネラル、葉緑素などの栄養成分に富んだ緑葉の粉末を製造するためには、間歇的蒸煮処理を2〜5回繰り返すことが好ましい。 The blanching process is a process for keeping the green color of the green leaves vivid, and examples of the blanching process include a hot water process and a steaming process. In the blanching treatment, the green leaves are preferably treated in hot water or steam at 80 to 100 ° C., preferably 90 to 100 ° C. for 60 to 180 seconds, preferably 90 to 120 seconds. In addition, when performing hydrothermal treatment as a blanching treatment, the green color of green leaves can be made more vivid by dissolving carbonates such as magnesium carbonate and hydrogen carbonates such as sodium bicarbonate in hot water. This is preferable because it is possible. Moreover, as a steaming process, the intermittent steaming process which repeats the process which steams a green leaf with water vapor | steam, and the process which cools under normal pressure or pressurization is preferable. In the intermittent steaming process, the steaming process is preferably performed for 20 to 40 seconds, more preferably 30 seconds. The cooling treatment after the steaming treatment is preferably performed immediately, and the method is not particularly limited, but the method is not particularly limited, soaking in cold water, refrigeration, cooling with cold air, evaporative cooling with hot air, evaporative cooling combining hot air and cold air Etc. are used. Among these, evaporative cooling combining hot air and cold air is preferable. Such cooling treatment is performed so that the temperature of the green leaves is preferably 60 ° C. or lower, more preferably 50 ° C. or lower, and most preferably 40 ° C. or lower. Moreover, in order to produce a green leaf powder rich in nutritional components such as vitamins, minerals, and chlorophyll, it is preferable to repeat the intermittent steaming treatment 2 to 5 times.
殺菌処理とは、通常、温度・圧力・電磁波・薬剤等を用いて物理的・化学的に微生物細胞を殺滅させる処理である。乾燥処理及び粉砕処理に追加してブランチング処理を行う場合、ブランチング処理は乾燥処理の前に行われることが好ましい。また乾燥処理及び粉砕処理に追加して殺菌処理を行う場合、殺菌処理は、乾燥処理の後か、粉砕処理の前又は後に行われることが好ましい。 The sterilization treatment is usually a treatment for physically and chemically killing microbial cells using temperature, pressure, electromagnetic waves, chemicals and the like. When the branching process is performed in addition to the drying process and the pulverization process, the branching process is preferably performed before the drying process. Moreover, when performing a sterilization treatment in addition to the drying treatment and the pulverization treatment, the sterilization treatment is preferably performed after the drying treatment or before or after the pulverization treatment.
乾燥処理としては、緑葉の水分含量が10質量%以下、特に7質量%以下となるように乾燥する処理であることが好ましい。この乾燥処理は、例えば、熱風乾燥、高圧蒸気乾燥、電磁波乾燥、凍結乾燥などの当業者に公知の任意の方法により行われ得る。加熱による乾燥は、好ましくは40℃〜140℃、より好ましくは80〜130℃にて加温により緑葉が変色しない温度及び時間で行われうる。 The drying treatment is preferably a treatment for drying so that the water content of the green leaves is 10% by mass or less, particularly 7% by mass or less. This drying treatment can be performed by any method known to those skilled in the art, such as hot air drying, high pressure steam drying, electromagnetic wave drying, freeze drying, and the like. Drying by heating can be performed at a temperature and a time at which green leaves are not discolored by heating, preferably at 40 ° C to 140 ° C, more preferably 80 to 130 ° C.
粉砕処理としては、クラッシャー、ミル、ブレンダー、石臼などを用いて当業者が通常使用する任意の方法により粉砕する処理が挙げられる。粉砕された緑葉は必要に応じて篩にかけられる。 Examples of the pulverization treatment include a pulverization treatment by an arbitrary method commonly used by those skilled in the art using a crusher, a mill, a blender, a stone mortar or the like. The pulverized green leaves are sieved as necessary.
具体的な乾燥粉末化(粉砕末化)の方法としては、例えば、緑葉を切断した後、ブランチング処理を行い、次いで水分含量が10質量%以下、好ましくは7質量%以下となるように乾燥し、その後粉砕する方法が挙げられる(特開2004−000210号公報を参照)。また例えば、緑葉を切断した後、ブランチング処理を行い、次いで揉捻し、その後、乾燥し、粉砕する方法(特開2002−065204号公報、特許第3428956号公報を参照)も挙げられる。また例えば、緑葉を乾燥し、粗粉砕した後、110℃以上で加熱し、更に微粉砕する方法(特開2003−033151号公報、特許第3277181号公報を参照)も挙げられる。 As a specific dry powdering (pulverized powder) method, for example, after cutting green leaves, a blanching treatment is performed, and then dried so that the water content is 10% by mass or less, preferably 7% by mass or less. Then, a method of pulverizing is mentioned (see JP 2004000210 A). Further, for example, a method of cutting green leaves, performing branching treatment, then twisting, and then drying and pulverizing (see Japanese Patent Application Laid-Open No. 2002-0665204 and Japanese Patent No. 3428956) can also be mentioned. Further, for example, a method of drying green leaves, coarsely pulverizing them, heating them at 110 ° C. or higher, and further finely pulverizing them (see Japanese Patent Application Laid-Open No. 2003-033151 and Japanese Patent No. 3277181) can be mentioned.
緑葉を細片化する方法としては、スライス、破砕、細断等、当業者が植物体を細片化する際に通常使用する方法を用いることができる。細片化の一例として、スラリー化してもよい。スラリー化は、大麦の緑葉をミキサー、ジューサー、ブレンダー、マスコロイダーなどにかけ、大麦の緑葉をどろどろした粥状(液体と固体の懸濁液)にすることにより行う。このようにスラリー化することにより、緑葉は、細片の80質量%以上が好ましくは平均径1mm以下、より好ましくは0.5mm以下、一層好ましくは0.1mm以下、最も好ましくは0.05mmとなるように細片化され、流動性を有するようになる。 As a method for fragmenting the green leaves, methods commonly used by those skilled in the art to fragment a plant body, such as slicing, crushing, and chopping, can be used. As an example of fragmentation, a slurry may be used. Slurry is performed by putting barley green leaves through a mixer, a juicer, a blender, a mascoloider, etc., and making the barley green leaves into a cocoon (liquid and solid suspension). By slurrying in this way, the green leaves are preferably 80% by mass or more of the strips, preferably having an average diameter of 1 mm or less, more preferably 0.5 mm or less, even more preferably 0.1 mm or less, and most preferably 0.05 mm. It is made into pieces and has fluidity.
緑葉を搾汁する方法としては、緑葉又はその細片化物を圧搾するか、又は、大麦の緑葉の細片化物を遠心又はろ過する方法を挙げることができる。代表的な例としては、ミキサー、ジューサー等の機械的破砕手段によって搾汁し、必要に応じて、篩別、濾過等の手段によって粗固形分を除去することにより搾汁液を得る方法が挙げられる。具体的には、特開平08−245408号公報、特開平09−047252号公報、特開平5−7471号公報、特開平4−341153号公報などに記載の方法が挙げられ、これらの公知の方法を当業者が適宜選択して実施できる。 Examples of the method of squeezing green leaves include a method of squeezing green leaves or a fragmented product thereof, or a method of centrifuging or filtering a fragmented product of barley green leaves. A typical example is a method of squeezing juice by a mechanical crushing means such as a mixer or a juicer, and obtaining a squeezed liquid by removing coarse solids by means such as sieving or filtration, if necessary. . Specific examples include the methods described in JP-A-08-245408, JP-A-09-047252, JP-A-5-7471, JP-A-4-341153, and the like. Can be appropriately selected and implemented by those skilled in the art.
緑葉のエキスを得る方法としては、緑葉又はその細片化物に、エタノール、水、含水エタノールなどの当業者が通常用いる抽出溶媒を加え、必要に応じて攪拌や加温して抽出する方法を挙げることができる。抽出物は、必要に応じて濃縮してもよい。 As a method for obtaining a green leaf extract, an extraction solvent usually used by those skilled in the art, such as ethanol, water, hydrous ethanol, or the like, is added to green leaf or a fragmented product thereof, and extraction is performed by stirring or heating as necessary. be able to. The extract may be concentrated as necessary.
本実施形態の緑葉粉末は後述する実施例に記載の通り、特定のケイ素含有量を有することにより、筋芽細胞賦活効果、筋芽細胞分化促進効果及び脂肪細胞分化抑制効果を奏する。具体的には、本実施形態の緑葉粉末及びそれを含む組成物を摂取することで、骨格筋等における筋芽細胞を活性化させ、且つ筋芽細胞の筋肉細胞への分化を促すことができ、また、繊維芽細胞等からの脂肪細胞の分化を抑制することができる。従って、本実施形態の組成物は、これを摂取することで筋肉増強促進や筋肉低減の防止を図り代謝を促進することができるため、脂肪組織低減促進や脂肪組織の増加防止を図ることができ、肥満の予防ないし低減を図ることができる。
従って、本実施形態の組成物は、筋芽細胞賦活用途、筋肉細胞増殖促進用途、脂肪細胞分化抑制用途、筋肉組織賦活用途、筋肉細胞増殖促進用途、筋肉量増加用途、脂肪組織低減用途、代謝促進用途、肥満の防止用途、肥満の予防用途、ダイエット用途、体脂肪低減用途等において、優れたものとなりうる。
また、本実施形態の組成物は、前記特定量以上のケイ素を含む緑葉粉末を含有することで、美容の向上にも有用であるものである。
The green leaf powder of the present embodiment has a specific silicon content, as described in the examples described later, and thereby has a myoblast activation effect, a myoblast differentiation promoting effect, and an adipocyte differentiation inhibiting effect. Specifically, by ingesting the green leaf powder of the present embodiment and a composition containing the same, it is possible to activate myoblasts in skeletal muscles and promote differentiation of myoblasts into muscle cells. Moreover, differentiation of adipocytes from fibroblasts can be suppressed. Therefore, since the composition of this embodiment can promote muscle strengthening and prevention of muscle reduction and promote metabolism by ingesting it, it can promote adipose tissue reduction and prevention of adipose tissue increase. In addition, obesity can be prevented or reduced.
Therefore, the composition of this embodiment is used for myoblast activation, muscle cell proliferation promotion, adipocyte differentiation suppression, muscle tissue activation, muscle cell proliferation promotion, muscle mass increase, adipose tissue reduction, metabolism. It can be excellent in promotion applications, obesity prevention applications, obesity prevention applications, diet applications, body fat reduction applications, and the like.
Moreover, the composition of this embodiment is useful also for the improvement of beauty by containing the green leaf powder containing the silicon more than the said specific amount.
以下、実施例を示して本発明を更に具体的に説明するが、本発明の範囲は、これらの実施例に限定されるものではない。 EXAMPLES Hereinafter, although an Example is shown and this invention is demonstrated further more concretely, the scope of the present invention is not limited to these Examples.
[実施例1]
黒ボク土(推定でケイ素をSiO2換算で30質量%程度含有)の圃場に大麦の種を播種した。給水や雑草管理などの通常の植物栽培法により、大麦を栽培した。黒ボク土の土壌分析データの一例は表1のとおりである。
大麦から、出穂前における大麦の茎を含む緑葉を刈り取った。これを水洗いし、付着した泥などを除去し、5〜10cm程度の大きさに切断する前処理を行った。前処理した緑葉を、90〜100℃の熱湯で90秒間〜120秒間、1回のみブランチング処理し、その後、冷水で冷却した。続いて、得られた緑葉を、水分量が10質量%以下となるまで、乾燥機中で、20分間〜180分間、80℃〜130℃の温風にて乾燥させた。乾燥した緑葉を約1mmの大きさに粗粉砕処理した。得られた大麦の緑葉を、200メッシュ区分を90質量%以上が通過するように微粉砕処理し、大麦茎葉の乾燥粉末(粉砕末)試料を得た。緑葉の粉末試料は、200メッシュを通過するものが90質量%以上であり、水分量が1質量%以上7質量%以下であった。
[Example 1]
Barley seeds were sown in a field of black soil (presumably containing about 30% by mass of silicon in terms of SiO 2 ). Barley was cultivated by usual plant cultivation methods such as water supply and weed management. An example of soil analysis data of Kuroboku soil is shown in Table 1.
From the barley, green leaves including barley stems before heading were cut. This was washed with water to remove adhering mud and the like, and a pretreatment was performed to cut it to a size of about 5 to 10 cm. The pretreated green leaves were blanched only once with hot water at 90 to 100 ° C. for 90 to 120 seconds, and then cooled with cold water. Subsequently, the obtained green leaves were dried with warm air at 80 ° C. to 130 ° C. for 20 minutes to 180 minutes in a dryer until the water content became 10% by mass or less. The dried green leaves were roughly crushed to a size of about 1 mm. The obtained green leaves of barley were finely pulverized so that 90% by mass or more passed through the 200 mesh section to obtain a dry powder (ground powder) sample of barley foliage. The green leaf powder sample passed through 200 mesh was 90% by mass or more, and the water content was 1% by mass to 7% by mass.
[実施例2]
各種クマザサ粉砕末を、ケイ素含有量に基づいてスクリーニングを行い、ケイ素含有量が34,900ppmのものを用いた。
[Example 2]
Various Kumazasa pulverized powders were screened based on the silicon content, and those having a silicon content of 34,900 ppm were used.
[実施例3]
各種大麦緑葉粉砕末を、ケイ素含有量に基づいてスクリーニングを行い、ケイ素含有量が5,650ppmのものを用いた。
[Example 3]
Various barley green leaf pulverized powders were screened based on the silicon content, and those having a silicon content of 5,650 ppm were used.
[比較例1]
市販の明日葉の粉砕末を用いた。
[Comparative Example 1]
A commercially available powder of tomorrow leaves was used.
[比較例2]
実施例1と同様にしてケールを栽培し、得られた茎を含む葉を実施例1と同様に処理することで、緑葉の乾燥粉末試料を得た。緑葉の粉末試料は、200メッシュを通過するものが90質量%以上であった。
[Comparative Example 2]
Kale was cultivated in the same manner as in Example 1, and the leaf containing the obtained stem was treated in the same manner as in Example 1 to obtain a dry powder sample of green leaves. The green leaf powder sample that passed through 200 mesh was 90% by mass or more.
<ケイ素含有量の測定>
得られた粉末のケイ素含有量はICP発光分析法(一般財団法人 日本食品分析センターにて測定)を用いて測定を行った。結果を表2に示す。
<Measurement of silicon content>
The silicon content of the obtained powder was measured using an ICP emission analysis method (measured at the Japan Food Analysis Center). The results are shown in Table 2.
実施例1〜3並びに比較例1の粉末を、下記(1)〜(7)の手順の筋細胞賦活試験に供した。
[筋細胞賦活試験]
(1)マウス骨格筋由来筋芽細胞(品名C2C12、理化学研究所バイオリソースセンター製)を37℃、5 %CO2インキュベーター内で、10vol%FBS-DMEM培地を入れた75cm2フラスコを用いて、培養した。
(2)(1)の培養後、トリプシン処理により浮遊させた細胞を75cm2フラスコから回収し、細胞数を計測した後、コラーゲンコートした96 well plateにおける各wellに、4000cells/wellの細胞密度にて培地ごと播種した後、37℃、5%CO2インキュベーター内で24時間前培養した。
(3)(1)及び(2)とは別に、実施例1〜3並びに比較例1の粉末をそれぞれ、10容量%FBS-DMEM培地に500μg/ml濃度となるように分散又は溶解させた液を調製し、これを0.2μmフィルター(アドバンテック製)を用いてフィルター滅菌したものをサンプル液とした。コントロールとしては、10vol%FBS-DMEM培地そのものをサンプル液として用いた。
(4)各wellより培地を除去後、(3)で調製したサンプル液を各wellにそれぞれ200μLずつ添加し、37℃、5%CO2インキュベーター内で24時間培養した。
(5)(4)の培養後、培地を除去した後、各wellをPBS 200μL/wellで1回洗浄した。次いで、無血清DMEMで30倍に希釈したCell Counting Kit−8溶液(同仁化学社) 150μL/wellを添加した。
(6)(5)の溶液添加後のplateを37℃、5%CO2インキュベーター内に静置して適度に発色させた後、各wellの450nmにおける吸光度を測定した。得られたデータを元に、コントロールに対する細胞数の割合(% of control)を下記式に基づいて算出し、これを筋芽細胞賦活活性とした。
% of control=(Data sample - Data blank)/(Data control - Data blank)×100
Data sample:実施例1〜3並びに比較例1の吸光度
Data control:controlの吸光度
Data blank:細胞がないときのブランク
The powders of Examples 1 to 3 and Comparative Example 1 were subjected to a myocyte activation test according to the following procedures (1) to (7).
[Myocyte activation test]
(1) Mouse skeletal muscle-derived myoblasts (product name C2C12, manufactured by RIKEN BioResource Center) are cultured in a 75 cm 2 flask containing 10 vol% FBS-DMEM medium at 37 ° C in a 5% CO 2 incubator. did.
(2) After culturing in (1), cells suspended by trypsin treatment were collected from a 75 cm 2 flask, and after counting the number of cells, each well in a 96-well plate coated with collagen had a cell density of 4000 cells / well. After inoculating the whole medium, it was precultured for 24 hours in a 37 ° C., 5% CO 2 incubator.
(3) Separately from (1) and (2), a solution obtained by dispersing or dissolving the powders of Examples 1 to 3 and Comparative Example 1 in a 10% by volume FBS-DMEM medium to a concentration of 500 μg / ml. A sample solution was prepared by sterilizing the filter using a 0.2 μm filter (manufactured by Advantech). As a control, 10 vol% FBS-DMEM medium itself was used as a sample solution.
(4) After removing the medium from each well, 200 μL each of the sample solution prepared in (3) was added to each well and cultured in a 37 ° C., 5% CO 2 incubator for 24 hours.
(5) After culturing in (4), the medium was removed, and each well was washed once with PBS 200 μL / well. Subsequently, 150 μL / well of Cell Counting Kit-8 solution (Dojin Chemical Co., Ltd.) diluted 30-fold with serum-free DMEM was added.
(6) The plate after the addition of the solution in (5) was allowed to stand in a 37 ° C., 5% CO 2 incubator for appropriate color development, and then the absorbance of each well at 450 nm was measured. Based on the obtained data, the ratio of the number of cells to the control (% of control) was calculated based on the following formula, and this was defined as myoblast activation activity.
% of control = (Data sample-Data blank) / (Data control-Data blank) × 100
Data sample: Absorbance of Examples 1 to 3 and Comparative Example 1
Data control: Absorbance of control
Data blank: Blank when there is no cell
(7)評価
コントロールを100%として、実施例1〜3並びに比較例1の細胞数の割合の算出結果をまとめたものを図1に示す。
(7) Evaluation FIG. 1 shows a summary of the calculation results of the ratio of the number of cells in Examples 1 to 3 and Comparative Example 1 with the control as 100%.
図1に示すように、各実施例の粉末によれば、筋細胞の賦活効果が得られた。特に大麦緑葉粉末の筋細胞賦活効果は高かった。これに対し、各比較例では筋細胞の賦活効果が低いものであった。 As shown in FIG. 1, according to the powder of each Example, the activation effect of the myocyte was acquired. Especially, the myocyte activation effect of barley green leaf powder was high. On the other hand, in each comparative example, the activation effect of myocytes was low.
次いで、実施例1〜3並びに比較例1及び2の粉末を、下記(a)〜(f)の手順により、筋芽細胞の分化マーカーであるMyogenin遺伝子発現試験に供した。 Next, the powders of Examples 1 to 3 and Comparative Examples 1 and 2 were subjected to the Myogenin gene expression test, which is a differentiation marker for myoblasts, according to the following procedures (a) to (f).
[Myogenin遺伝子発現試験]
(a)マウス骨格筋由来筋芽細胞(品名C2C12、理化学研究所バイオリソースセンター製)を37℃、5 %CO2インキュベーター内で、10vol%FBS-DMEM培地を入れた75cm2フラスコを用いて、培養した。
(b)(a)の培養後、トリプシン処理により浮遊させた細胞を75cm2フラスコから回収し、細胞数を計測した後、コラーゲンコートした24well plateにおける各wellに、2×104cells/wellの細胞密度にて培地ごと播種した後、37℃、5 %CO2インキュベーター内で、96時間前培養した。
(c)(a)及び(b)とは別に、実施例1〜3並びに比較例1及び2の粉末をそれぞれ、10vol%FBS-DMEM培地に、1000μg/ml濃度となるように分散又は溶解させた液を調製し、これを0.2μmフィルター(アドバンテック)を用いてフィルター滅菌したものをサンプル液とした。コントロールとしては、10vol%FBS-DMEM培地そのものをサンプル液とした。
(d)各wellより培地を除去後、(c)で調製したサンプル液を各wellにそれぞれ500μL添加し、37℃、5%CO2インキュベーター内で24時間培養した。
(e)(d)の培養後、各wellをPBS 500μL/wellで2回洗浄した。次いでRNeasy Mini Kit 250(QIAGEN製)を用いてmRNAを回収した。得られたmRNAを鋳型とし、 ReverTra Ace(登録商標) qPCR RT Master Mixwith gDNA Remover(東洋紡製)を用いてcDNAを合成した。
(f)(e)で得られたcDNAを鋳型として、下記のプライマー(QIAGEN製)を用いて、QuantiNova SYBR Green PCR Kit(QIAGEN製)により定量リアルタイムPCRを行い、Gapdh及びMyogeninのmRNA発現量を測定した。
Gapdh:Mm_Gapdh_3_SG QuantiTect Primer Assay (QT01658692)
Myog:Mm_Myog_1_SG QuantiTect Primer Assay (QT00112378)
[Myogenin gene expression test]
(A) Culture of mouse skeletal muscle-derived myoblasts (product name C2C12, manufactured by RIKEN BioResource Center) at 37 ° C in a 5% CO 2 incubator using a 75cm 2 flask containing 10vol% FBS-DMEM medium. did.
(B) After culturing in (a), cells suspended by trypsin treatment were collected from a 75 cm 2 flask and the number of cells was counted. Then, 2 × 10 4 cells / well were added to each well in a collagen-coated 24-well plate. After inoculating the medium at the cell density, the cells were precultured for 96 hours in a 37 ° C., 5% CO 2 incubator.
(C) Separately from (a) and (b), the powders of Examples 1 to 3 and Comparative Examples 1 and 2 were dispersed or dissolved in a 10 vol% FBS-DMEM medium to a concentration of 1000 μg / ml. A sample solution was prepared by sterilizing the solution using a 0.2 μm filter (Advantech). As a control, 10 vol% FBS-DMEM medium itself was used as a sample solution.
(D) After removing the medium from each well, 500 μL of the sample solution prepared in (c) was added to each well and cultured in a 37 ° C., 5% CO 2 incubator for 24 hours.
(E) After culturing in (d), each well was washed twice with 500 μL / well of PBS. Subsequently, mRNA was recovered using RNeasy Mini Kit 250 (manufactured by QIAGEN). Using the obtained mRNA as a template, cDNA was synthesized using ReverTra Ace (registered trademark) qPCR RT Master Mix with gDNA Remover (manufactured by Toyobo).
(F) Quantitative real-time PCR using QuantiNova SYBR Green PCR Kit (manufactured by QIAGEN) using the cDNA obtained in (e) as a template and the following primers (manufactured by QIAGEN) to determine the mRNA expression levels of Gapdh and Myogenin. It was measured.
Gapdh: Mm_Gapdh_3_SG QuantiTect Primer Assay (QT01658692)
Myog: Mm_Myog_1_SG QuantiTect Primer Assay (QT00112378)
解析は相対定量により行い、GapdhのmRNA発現量を内在性コントロールとしてmRNA量を補正した。)各実施例及び各比較例の補正後のMyogenin遺伝子発現量について、補正後のコントロール(分化誘導をかけ、サンプルを加えていない群)の遺伝子発現量を1とした相対値を算出した。結果を図2に示す。 The analysis was performed by relative quantification, and the mRNA amount was corrected using the Gapdh mRNA expression level as an endogenous control. ) With respect to the corrected Myogenin gene expression level in each example and each comparative example, a relative value was calculated with the corrected gene expression (group in which differentiation induction was applied and no sample was added) as 1. The results are shown in FIG.
図2に示すように、各実施例の粉末により、筋芽細胞におけるMyogenin遺伝子発現向上効果が得られた。特に大麦緑葉粉末の発現向上効果は高かった。これに対し、各比較例では筋芽細胞のMyogenin遺伝子発現が低いものであった。 As shown in FIG. 2, the Myogenin gene expression improving effect in myoblasts was obtained by the powder of each example. In particular, the improvement effect of barley green leaf powder was high. In contrast, in each of the comparative examples, myogenin gene expression in myoblasts was low.
次いで、実施例1〜3並びに比較例1及び2の粉末を、下記(1)〜(11)の手順により脂肪細胞の分化抑制試験に供した。
[3T3-L1細胞における遺伝子発現による脂肪細胞の分化抑制試験]
(1)マウス繊維芽細胞3T3-L1(理化学研究所バイオリソースセンター)を10vol%FBS-DMEM培地を入れた75cm2フラスコを用いて、所定の数になるまで、5%CO2インキュベーター内で、37℃、湿潤条件で培養した。
(2)(1)のフラスコから培地を取り除き、DPBS(ナカライテスク社製)で3度洗浄した後、トリプシン処理により細胞を剥離した。
(3)新鮮な10vol%FBS-DMEM培地を加えてトリプシン反応を停止した後、細胞をチューブへ集め、遠心機で800rpm、3分遠心して細胞を沈殿させた。
(4)2×105 cells/mLになるように新鮮な10vol%FBS-DMEM培地に細胞を懸濁し、96 well plateに100μLずつ播種して、2日間、5%CO2インキュベーター内で、37℃、湿潤条件で前培養した。
(5)(1)〜(4)とは別に、IBMX(和光純薬社製)を0.5M、Dexamethasone(和光純薬社製)を1mMになるようにDMSOに溶解した。10vol%FBS−DMEM培地に前記で調製した0.5M IBMX及び1mM Dexamethasone並びに10mg/mL インスリン溶液(Sigma Aldrich社製)をそれぞれ終濃度が0.5mM、1μM、10μg/mLになるように添加して試験培地を調製した。実施例1〜3並びに比較例1及び2の粉末をそれぞれ、該試験培地に、10mg/mlとなるように分散又は溶解させた液を調製し、これを0.2μmフィルター(アドバンテック)を用いてフィルター滅菌したものをサンプル液とした。コントロールとしては、試験培地そのものをサンプル液とした。
(6)(4)で前培養した3T3-L1細胞から培地を除き、(5)で調製したサンプル液を各wellにそれぞれ100μLずつ添加し、1日間、5%CO2インキュベーター内で、37℃、湿潤条件で培養した。
(7)24時間後、各wellより培地を除き、細胞からRneasy mini(Qiagen社製)でRNAを精製した。
(8)精製したRNAより、ReverTra Ace(登録商標) qPCR RT Master Mix with gDNA Rem
over(東洋紡製)でcDNAを合成した。
(9)(8)で得られたcDNAを鋳型として、内部標準としてRps28(Mm_Rps28_1_SG QuantiTect Primer Assay、Qiagen社製)のプライマー、測定遺伝子としてCol1A1(Mm_Col1a1_1_SG QuantiTect primer assay、Qiagen社製)のプライマー、QuantiNOVA SYBR GREEN(Qiagen社製)を用いて、Rotor-Gene Q(Qiagen社製)でPCRを行った。
(10)PCRの結果は、Rotor Gene Q Pure Detection(Qiagen社製)を用い、Rps28及びCol1A1のmRNA発現量を解析した。解析は相対定量により行い、Rps28のmRNA発現量を内在性コントロールとしてmRNA量を補正した。
(11)各実施例及び各比較例の補正後のCol1A1遺伝子発現量について、補正後のコントロール(分化誘導をかけ、サンプルを加えていない群)の遺伝子発現量を1とした相対値を算出した。結果を図3に示す。
Subsequently, the powders of Examples 1 to 3 and Comparative Examples 1 and 2 were subjected to an adipocyte differentiation inhibition test according to the following procedures (1) to (11).
[Adipocyte differentiation inhibition test by gene expression in 3T3-L1 cells]
(1) Using mouse fibroblast 3T3-L1 (RIKEN BioResource Center) in a 75 cm 2 flask containing 10 vol% FBS-DMEM medium, in a 5% CO 2 incubator until it reaches a predetermined number, 37 Culturing was carried out under humid conditions at ° C.
(2) The medium was removed from the flask in (1), washed 3 times with DPBS (manufactured by Nacalai Tesque), and the cells were detached by trypsin treatment.
(3) After stopping the trypsin reaction by adding fresh 10 vol% FBS-DMEM medium, the cells were collected in a tube and centrifuged at 800 rpm for 3 minutes to precipitate the cells.
(4) Suspend cells in fresh 10vol% FBS-DMEM medium to 2 × 10 5 cells / mL, seed 100 μL each in a 96 well plate, and in a 5% CO 2 incubator for 2 days, 37 Pre-cultured at a temperature of 0 ° C. under humid conditions.
(5) Apart from (1) to (4), IBMX (manufactured by Wako Pure Chemical Industries, Ltd.) was dissolved in DMSO so that 0.5M and Dexamethasone (manufactured by Wako Pure Chemical Industries, Ltd.) were 1 mM. Test by adding 0.5 M IBMX and 1 mM Dexamethasone prepared above and 10 mg / mL insulin solution (manufactured by Sigma Aldrich) to 10 vol% FBS-DMEM medium to final concentrations of 0.5 mM, 1 μM and 10 μg / mL, respectively. A medium was prepared. A liquid in which the powders of Examples 1 to 3 and Comparative Examples 1 and 2 were dispersed or dissolved in the test medium so as to be 10 mg / ml was prepared, and this was filtered using a 0.2 μm filter (Advantech). The sterilized product was used as a sample solution. As a control, the test medium itself was used as a sample solution.
(6) Remove the medium from the 3T3-L1 cells pre-cultured in (4), add 100 μL of the sample solution prepared in (5) to each well, and in a 5% CO 2 incubator for 1 day at 37 ° C. The cells were cultured under humid conditions.
(7) After 24 hours, the medium was removed from each well, and RNA was purified from the cells using Rneasy mini (Qiagen).
(8) ReverTra Ace (registered trademark) qPCR RT Master Mix with gDNA Rem
cDNA was synthesized by over (Toyobo).
(9) Rps28 (Mm_Rps28_1_SG QuantiTect Primer Assay, Qiagen) primer as internal standard, Col1A1 (Mm_Col1a1_1_SG QuantiTect primer assay, Qiagen) primer, QuantiNOVA as internal standard, using cDNA obtained in (8) as a template PCR was performed with Rotor-Gene Q (Qiagen) using SYBR GREEN (Qiagen).
(10) As a result of PCR, mRNA expression levels of Rps28 and Col1A1 were analyzed using Rotor Gene Q Pure Detection (manufactured by Qiagen). The analysis was performed by relative quantification, and the amount of mRNA was corrected using the amount of Rps28 mRNA expressed as an endogenous control.
(11) For the corrected Col1A1 gene expression level in each example and each comparative example, a relative value was calculated with the corrected gene expression (group in which differentiation was induced and no sample was added) as 1. . The results are shown in FIG.
図3に示すように、各実施例の緑葉粉末の存在下において、繊維芽細胞3T3-L1細胞を脂肪細胞へ分化誘導処理した場合、誘導処理後の繊維芽細胞3T3-L1においてCol1A1遺伝子発現向上効果が得られた。特に大麦緑葉粉末の発現向上効果は高かった。これに対し、各比較例では脂肪細胞の分化誘導後のCol1A1遺伝子発現が低いものであった。Col1A1遺伝子は繊維芽細胞マーカーであり、繊維芽細胞3T3-L1を脂肪細胞に分化誘導すると、ごく初期にCol1A1遺伝子の遺伝子発現量が激減してしまうことが知られている。従って、Col1A1遺伝子が大きいことは、脂肪細胞への分化が抑制されていることを示す。本試験により、本願発明の緑葉粉末により、繊維芽細胞からの脂肪細胞への分化が効果的に抑制されることが示された。
As shown in FIG. 3, when fibroblast 3T3-L1 cells are induced to differentiate into adipocytes in the presence of the green leaf powder of each example, the expression of Col1A1 gene is improved in fibroblast 3T3-L1 after the induction treatment. The effect was obtained. In particular, the effect of improving the expression of barley green leaf powder was high. In contrast, in each of the comparative examples, the expression of the Col1A1 gene after induction of adipocyte differentiation was low. The Col1A1 gene is a fibroblast marker, and it is known that when the fibroblast 3T3-L1 is induced to differentiate into adipocytes, the expression level of the Col1A1 gene is drastically reduced very early. Therefore, a large Col1A1 gene indicates that differentiation into adipocytes is suppressed. From this test, it was shown that differentiation from fibroblasts into adipocytes is effectively suppressed by the green leaf powder of the present invention.
本発明は、緑葉粉末及びそれを用いた組成物に関する。
The present invention relates to green leaf powder and composition using the same.
以下、本発明の緑葉粉末及び組成物並びに該緑葉粉末の好適な製造方法について、その好ましい実施形態に基づいて説明する。本実施形態の緑葉粉末は、ケイ素含有量が質量基準で1,000ppm以上である経口用の緑葉粉末である。また本実施形態の組成物は、ケイ素含有量が質量基準で1,000ppm以上である緑葉粉末を含有するものである。以下、本実施形態の組成物という場合、青汁用の飲食用組成物、ダイエット用組成物及び美容用組成物のいずれにも当てはまる。 Hereinafter, the green leaf powder and compositions and preferred method for producing the green leaf powder of the present invention will be described with reference to preferred embodiments thereof. The green leaf powder of this embodiment is an oral green leaf powder having a silicon content of 1,000 ppm or more on a mass basis. Moreover, the composition of this embodiment contains the green leaf powder whose silicon content is 1,000 ppm or more on a mass basis. Hereinafter, the composition of the present embodiment applies to any of the composition for eating and drinking for green juice, the composition for diet and the cosmetic composition.
Claims (5)
A cosmetic composition comprising green leaf powder having a silicon content of 1,000 ppm or more on a mass basis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016252075A JP6829461B2 (en) | 2016-12-26 | 2016-12-26 | Green leaf powder and composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016252075A JP6829461B2 (en) | 2016-12-26 | 2016-12-26 | Green leaf powder and composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018102202A true JP2018102202A (en) | 2018-07-05 |
JP6829461B2 JP6829461B2 (en) | 2021-02-10 |
Family
ID=62785433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016252075A Active JP6829461B2 (en) | 2016-12-26 | 2016-12-26 | Green leaf powder and composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6829461B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020054253A (en) * | 2018-09-28 | 2020-04-09 | 株式会社東洋新薬 | Oral composition |
JP2020063216A (en) * | 2018-10-18 | 2020-04-23 | 株式会社東洋新薬 | Oral composition |
JP2021004211A (en) * | 2019-06-26 | 2021-01-14 | 株式会社東洋新薬 | Amino acid absorption promoting composition |
JP2021166544A (en) * | 2019-10-23 | 2021-10-21 | 株式会社東洋新薬 | Oral composition |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030217823A1 (en) * | 2002-05-09 | 2003-11-27 | Jie Zhu | Method for producing pulp and products from high silica content agricultural waste materials |
JP2013183723A (en) * | 2012-03-09 | 2013-09-19 | Setsuko Komatsubara | Reed/ashwagandha beverage |
CN104973904A (en) * | 2014-04-11 | 2015-10-14 | 王忠厚 | Water-soluble Si/Ca/K mineral element ecological organic fertilizer and preparation method |
-
2016
- 2016-12-26 JP JP2016252075A patent/JP6829461B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030217823A1 (en) * | 2002-05-09 | 2003-11-27 | Jie Zhu | Method for producing pulp and products from high silica content agricultural waste materials |
JP2013183723A (en) * | 2012-03-09 | 2013-09-19 | Setsuko Komatsubara | Reed/ashwagandha beverage |
CN104973904A (en) * | 2014-04-11 | 2015-10-14 | 王忠厚 | Water-soluble Si/Ca/K mineral element ecological organic fertilizer and preparation method |
Non-Patent Citations (3)
Title |
---|
ヨシを原料とした活性炭の作製、山口環保研業報、[ONLINE]、第23号(2002年)、[検索日:2020年, JPN7020003349, ISSN: 0004371505 * |
原料・受託バンク ニュース一覧(原料:大麦若葉)、[ONLINE]、2016年10月17日、[検索日:202, JPN7020003348, ISSN: 0004371504 * |
大麦若葉特集(2016)_特集_健康創造メディア、[ONLINE]、2016年、[検索日:2020年10月1, JPN7020003347, ISSN: 0004371503 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020054253A (en) * | 2018-09-28 | 2020-04-09 | 株式会社東洋新薬 | Oral composition |
JP2020063216A (en) * | 2018-10-18 | 2020-04-23 | 株式会社東洋新薬 | Oral composition |
JP2021004211A (en) * | 2019-06-26 | 2021-01-14 | 株式会社東洋新薬 | Amino acid absorption promoting composition |
JP7385243B2 (en) | 2019-06-26 | 2023-11-22 | 株式会社東洋新薬 | Composition for promoting amino acid absorption |
JP2021166544A (en) * | 2019-10-23 | 2021-10-21 | 株式会社東洋新薬 | Oral composition |
JP2022095986A (en) * | 2019-10-23 | 2022-06-28 | 株式会社東洋新薬 | Oral composition |
JP7500090B2 (en) | 2019-10-23 | 2024-06-17 | 株式会社東洋新薬 | Oral Compositions |
Also Published As
Publication number | Publication date |
---|---|
JP6829461B2 (en) | 2021-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7455412B2 (en) | Composition for food and drink, method for improving taste and color of composition for food and drink, composition for propagating lactic acid bacteria, method for cultivating barley stems and leaves, barley stems and leaves grown using Aso or Kuroboku soil | |
JP6829461B2 (en) | Green leaf powder and composition | |
KR101261823B1 (en) | Precess of enzyme health food having high activity bymicrobial fermentation | |
CN105166899A (en) | Fragrance flavored fruit and vegetable enzyme powder preparation method | |
Rubel et al. | Inulin from Jerusalem artichoke (Helianthus tuberosus L.): From its biosynthesis to its application as bioactive ingredient | |
JP2022028043A (en) | Barley leaf and/or stem cultivated using andosols, aso-grown barley leaf and/or stem and edible composition including the same, and method for cultivating barley stem and/or leaf | |
CN105076648A (en) | Blueberry tablet candy with beautifying and antibacterial efficacy and preparation method thereof | |
KR20210143172A (en) | Anti-obesity activator and method for suppressing obesity using allitol as an active ingredient | |
KR20170061327A (en) | Anti-obesity compositions and methods of manufacturing the same as a main component of raspberry leaf and stem extract | |
JP2008136391A (en) | Young leaf composition | |
KR20170086196A (en) | Rice bran composition and preparing method for fermented rice bran composition | |
JP6872699B2 (en) | Composition for promoting calcium absorption | |
CN105166257A (en) | Probiotic blueberry press candy and preparation method thereof | |
JP2019041661A (en) | Health food | |
Stiti et al. | Agri-food valuation of oak fruits in human consumption: Formulation of desserts | |
RU2662935C2 (en) | Mutant tomato and its application for prevention of weight gain and/or for treatment of the pathological state coming from obesity | |
Seleim et al. | Changes in nutritional quality of zucchini (Cucurbita pepo L.) vegetables during the maturity | |
KR102596424B1 (en) | Manufacturing method of mandarin dessert | |
JP6089165B1 (en) | Bifidobacterium composition | |
JP6051353B2 (en) | Blood cholesterol elevation inhibitor | |
JP7236169B2 (en) | Composition | |
WO2023195538A1 (en) | Potato syrup powder formed from powder or granules of sweet potato syrup, supernatant thereof, or both | |
JP5815083B2 (en) | Barley leaves and / or stems grown with black soil | |
JP7576815B2 (en) | Food and drink composition for green juice | |
JP2019110875A (en) | Composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170104 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20191220 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20201023 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20201027 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201221 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210105 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210107 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6829461 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |